Eolving attitudes to Alzheimer's disease among the general public and caregivers in Europe: Findings from the IMPACT survey

被引:18
|
作者
Wortmann, M. [1 ]
Andrieu, S. [2 ]
Mackell, J. [3 ]
Knox, S. [4 ]
机构
[1] Alzheimers Dis Int, London SE1 0BL, England
[2] Toulouse Univ Hosp, Dept Epidemiol & Publ Hlth, INSERM, U558, F-31073 Toulouse, France
[3] Pfizer Inc, New York, NY USA
[4] Eisai Europe Ltd, Hatfield, Herts, England
来源
JOURNAL OF NUTRITION HEALTH & AGING | 2010年 / 14卷 / 07期
关键词
Alzheimer's disease; caregivers; general public; survey; attitudes; ageing; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PRIMARY-CARE; DONEPEZIL; DEMENTIA; RIVASTIGMINE; GALANTAMINE; EFFICACY; MODERATE; 24-WEEK;
D O I
10.1007/s12603-010-0264-x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Understanding and appreciating the awareness of, and attitudes towards, Alzheimer's disease (AD) in the general public is of paramount importance to those charged with the development of health care policy. Furthermore, it is essential that this policy be formulated with consideration given to both the attitudes of the general population and to those within society more directly affected by AD; namely, the caregivers of patients with the disease. In the IMPACT survey, approximately 1000 members of the general public and 250 caregivers in 5 European countries (France, Germany, Italy, Spain, and the United Kingdom) completed a 30-minute, Web-based questionnaire. In this article, we compare and contrast the attitudes and opinions of these populations in an attempt to define specific themes. Indeed, caregivers were more concerned about consequences of growing old and were more fearful of AD than general public respondents, although a high proportion in both groups acknowledged the significant impact of the disease. Similarly, although most respondents in the 2 groups recognised that early signs and symptoms of AD are difficult to detect, caregivers were more skeptical of the abilities of both primary physicians and specialists to detect these early signs and symptoms. In terms of treatment, caregivers were less convinced of the effectiveness of treatment beyond the early stages of AD and more likely to agree that current treatments are associated with side effects. Respondents in both groups had a negative view of their government's investment in AD, but caregivers, particularly those in France, Spain and the United Kingdom, were more likely to feel that their government acts as a barrier to treatment. Some survey respondents from the 2 groups also had a negative view of their governments' attempts to raise awareness of AD and make its treatment a high priority. Overall, comparison of responses from these 2 groups suggests that caregivers' personal experiences of AD profoundly affect their attitudes and perceptions surrounding the disease.
引用
收藏
页码:531 / 536
页数:6
相关论文
共 50 条
  • [41] Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results
    Gooblar, Jonathan
    Roe, Catherine M.
    Selsor, Natalie J.
    Gabel, Matthew J.
    Morris, John C.
    JAMA NEUROLOGY, 2015, 72 (12) : 1484 - 1490
  • [42] Caregivers for patients with Alzheimer's disease benefit from intervention
    Perkins, Carlos, Jr.
    CNS SPECTRUMS, 2007, 12 (01) : 16 - 16
  • [43] Assessment of burden in caregivers of Alzheimer's disease from India
    Pattanayak, R. D.
    Jena, R.
    Tripathi, M.
    Khandelwal, S. K.
    ASIAN JOURNAL OF PSYCHIATRY, 2010, 3 (03) : 112 - 116
  • [44] BURDEN OF DISEASE IN CAREGIVERS OF ALZHEIMER'S DISEASE IN BRAZIL: RESULTS FROM 2011 NATIONAL HEALTH AND WELLNESS SURVEY (NHWS)
    Mould, J. F.
    Fujii, R. K.
    Paganini, P.
    Manfrin, D. F.
    VALUE IN HEALTH, 2012, 15 (04) : A148 - A149
  • [45] Quality of Care for Huntington's Disease in the United States: Findings from a National Survey of Patients and Caregivers
    Anderson, Karen E.
    Griffin, Jack
    Kinel, Al
    Shaikh, Abdul R.
    Olofintuyi, Temitope
    Ramirez, Stevan
    Steinman, Joni
    Yohrling, George J.
    Kinel, Shari
    JOURNAL OF HUNTINGTONS DISEASE, 2019, 8 (04) : 509 - 519
  • [46] Impact of Spina Bifida on Parental Caregivers: Findings from a Survey of Arkansas Families
    Grosse, Scott D.
    Flores, Alina L.
    Ouyang, Lijing
    Robbins, James M.
    Tilford, John M.
    JOURNAL OF CHILD AND FAMILY STUDIES, 2009, 18 (05) : 574 - 581
  • [47] Impact of Spina Bifida on Parental Caregivers: Findings from a Survey of Arkansas Families
    Scott D. Grosse
    Alina L. Flores
    Lijing Ouyang
    James M. Robbins
    John M. Tilford
    Journal of Child and Family Studies, 2009, 18 : 574 - 581
  • [48] ATTITUDES TOWARD DRUG PRICING IN THE US: FINDINGS FROM A SURVEY IN THE GENERAL POPULATION
    Jiang, R.
    Kuharic, M.
    Thompson, A.
    Pickard, A. S.
    VALUE IN HEALTH, 2019, 22 : S308 - S308
  • [49] Support for a tax increase to provide unrestricted access to an Alzheimer's disease medication: a survey of the general public in Canada
    Mark Oremus
    Jean-Eric Tarride
    Natasha Clayton
    Parminder Raina
    BMC Health Services Research, 9
  • [50] Support for a tax increase to provide unrestricted access to an Alzheimer's disease medication: a survey of the general public in Canada
    Oremus, Mark
    Tarride, Jean-Eric
    Clayton, Natasha
    Raina, Parminder
    BMC HEALTH SERVICES RESEARCH, 2009, 9